Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • CYB561 supports the neuroendoc...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
CYB561 supports the neuroendocrine phenotype in castration-resistant prostate cancer

CYB561 supports the neuroendocrine phenotype in castration-resistant prostate cancer

Show other versions (1)
Bibliographic Details
Main Authors: Romie Angelo G. Azur, Kevin Christian V. Olarte, Weand S. Ybañez, Alessandria Maeve M. Ocampo, Pia D. Bagamasbad
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11090301/?tool=EBI
  • Holdings
  • Description
  • Other Versions (1)
  • Similar Items
  • Staff View

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11090301/?tool=EBI

Similar Items

  • CYB561 supports the neuroendocrine phenotype in castration-resistant prostate cancer.
    by: Romie Angelo G Azur, et al.
    Published: (2024-01-01)
  • Krüppel-like factor 9 (KLF9) links hormone dysregulation and circadian disruption to breast cancer pathogenesis
    by: Weand S. Ybañez, et al.
    Published: (2023-02-01)
  • CYB561 is a potential therapeutic target for breast cancer and is associated with immune cell infiltration
    by: Jian Zhuo, et al.
    Published: (2024-08-01)
  • CYB561 promotes HER2+ breast cancer proliferation by inhibiting H2AFY degradation
    by: Ting Zhao, et al.
    Published: (2024-01-01)
  • CYB561D2 up-regulation activates STAT3 to induce immunosuppression and aggression in gliomas
    by: Bangbao Tao, et al.
    Published: (2021-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs